These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 34641563)

  • 21. Benextramine and derivatives as novel human monoamine oxidases inhibitors: an integrated approach.
    Di Paolo ML; Cozza G; Milelli A; Zonta F; Sarno S; Minniti E; Ursini F; Rosini M; Minarini A
    FEBS J; 2019 Dec; 286(24):4995-5015. PubMed ID: 31291696
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Design, synthesis, pharmacological evaluation, QSAR analysis, molecular modeling and ADMET of novel donepezil-indolyl hybrids as multipotent cholinesterase/monoamine oxidase inhibitors for the potential treatment of Alzheimer's disease.
    Bautista-Aguilera OM; Esteban G; Bolea I; Nikolic K; Agbaba D; Moraleda I; Iriepa I; Samadi A; Soriano E; Unzeta M; Marco-Contelles J
    Eur J Med Chem; 2014 Mar; 75():82-95. PubMed ID: 24530494
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Perspective on Monoamine Oxidase Enzyme as Drug Target: Challenges and Opportunities.
    Kumar B; Gupta VP; Kumar V
    Curr Drug Targets; 2017; 18(1):87-97. PubMed ID: 26648064
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of Monoamine Oxidase Activity in Alzheimer's Disease: An Insight into the Therapeutic Potential of Inhibitors.
    Behl T; Kaur D; Sehgal A; Singh S; Sharma N; Zengin G; Andronie-Cioara FL; Toma MM; Bungau S; Bumbu AG
    Molecules; 2021 Jun; 26(12):. PubMed ID: 34207264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Privileged scaffolds as MAO inhibitors: Retrospect and prospects.
    Tripathi AC; Upadhyay S; Paliwal S; Saraf SK
    Eur J Med Chem; 2018 Feb; 145():445-497. PubMed ID: 29335210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monoamine oxidase-B inhibitors as potential neurotherapeutic agents: An overview and update.
    Tripathi RKP; Ayyannan SR
    Med Res Rev; 2019 Sep; 39(5):1603-1706. PubMed ID: 30604512
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The interactions of caffeine with monoamine oxidase.
    Petzer A; Pienaar A; Petzer JP
    Life Sci; 2013 Aug; 93(7):283-7. PubMed ID: 23850513
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Predicting monoamine oxidase inhibitory activity through ligand-based models.
    Vilar S; Ferino G; Quezada E; Santana L; Friedman C
    Curr Top Med Chem; 2012; 12(20):2258-74. PubMed ID: 23231398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Drugs related to monoamine oxidase activity.
    Fišar Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():112-24. PubMed ID: 26944656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel monoamine oxidase inhibitors based on the privileged 2-imidazoline molecular framework.
    Shetnev A; Osipyan A; Baykov S; Sapegin A; Chirkova Z; Korsakov M; Petzer A; Engelbrecht I; Petzer JP
    Bioorg Med Chem Lett; 2019 Jan; 29(1):40-46. PubMed ID: 30455149
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoamine oxidase isoenzymes: genes, functions and targets for behavior and cancer therapy.
    Shih JC
    J Neural Transm (Vienna); 2018 Nov; 125(11):1553-1566. PubMed ID: 30259128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneously Detecting Monoamine Oxidase A and B in Disease Cell/Tissue Samples Using Paper-Based Devices.
    Fang H; Wu M; Ji W; Wang L; Chen Y; Chen D; Yang N; Wu Q; Yu C; Liu J; Liu J; Bai H; Peng B; Huang X; Yu HD; Li L
    ACS Appl Bio Mater; 2021 Feb; 4(2):1395-1402. PubMed ID: 35014490
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydride Abstraction as the Rate-Limiting Step of the Irreversible Inhibition of Monoamine Oxidase B by Rasagiline and Selegiline: A Computational Empirical Valence Bond Study.
    Tandarić T; Prah A; Stare J; Mavri J; Vianello R
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32858935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Monoamine Oxidases.
    Edmondson DE; Binda C
    Subcell Biochem; 2018; 87():117-139. PubMed ID: 29464559
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exploration of new scaffolds as potential MAO-A inhibitors using pharmacophore and 3D-QSAR based in silico screening.
    Shelke SM; Bhosale SH; Dash RC; Suryawanshi MR; Mahadik KR
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2419-24. PubMed ID: 21397504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 2-Styrylchromone derivatives as potent and selective monoamine oxidase B inhibitors.
    Takao K; Endo S; Nagai J; Kamauchi H; Takemura Y; Uesawa Y; Sugita Y
    Bioorg Chem; 2019 Nov; 92():103285. PubMed ID: 31561103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Monoamine oxidase as a target for drug action].
    Drozak J; Kozłowski M
    Postepy Hig Med Dosw (Online); 2006; 60():498-515. PubMed ID: 17060892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Inhibition of monoamine oxidase by benzoxathiolone analogues.
    Mostert S; Petzer A; Petzer JP
    Bioorg Med Chem Lett; 2016 Feb; 26(4):1200-4. PubMed ID: 26821818
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The inhibition of monoamine oxidase by phenformin and pentamidine.
    Barkhuizen M; Petzer A; Petzer JP
    Drug Res (Stuttg); 2014 Sep; 64(9):454-61. PubMed ID: 24307270
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Computer modelling of monoaminoxidases].
    Veselovsky AV; Ivanov AS; Medvedev AE
    Biomed Khim; 2015; 61(2):265-71. PubMed ID: 25978392
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.